• Explore /
  • Poster
  • / <span>Phase II randomized trial of neoadjuvant (NA) chemotherapy (CT) with or without bevacizumab (Bev) in advanced epithelial ovarian cancer (EOC)‏ (GEICO 1205/NOVA TRIAL).</span>

Phase II randomized trial of neoadjuvant (NA) chemotherapy (CT) with or without bevacizumab (Bev) in advanced epithelial ovarian cancer (EOC)‏ (GEICO 1205/NOVA TRIAL).

Abstract Poster

Authors

null

Yolanda García

Corporació Sanitaria Universitaria Parc Taulí, Universitat Autonoma de Barcelona, Barcelona, Spain

Yolanda García , Ana De Juan , Cesar Mendiola , Pilar Barretina-Ginesta , Laura Vidal , Ana Santaballa , Isabel Bover , Marta Gil-Martin , Aránzazu Manzano , M Jesus Rubio , Margarita Romeo , Alfonso Gomez de Liaño , Elena García-Martínez , Antonio Gonzalez-Martin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

NCT01847677

Citation

J Clin Oncol 33, 2015 (suppl; abstr 5531)

DOI

10.1200/jco.2015.33.15_suppl.5531

Abstract #

5531

Poster Bd #

89

Abstract Disclosures

Similar Posters

First Author: Gwenael Ferron

First Author: Jacek P. Grabowski

First Author: Wei-Chun Chen

Poster

2016 Gastrointestinal Cancers Symposium

A multicenter phase II study on the feasibility and efficacy of neoadjuvant chemotherapy for locally advanced rectal cancer.

A multicenter phase II study on the feasibility and efficacy of neoadjuvant chemotherapy for locally advanced rectal cancer.

First Author: Saori Goto